These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
795 related articles for article (PubMed ID: 28011467)
1. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review. Nguyen AH; Detty SQ; Agrawal DK Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467 [TBL] [Abstract][Full Text] [Related]
2. Ousting RAGE in melanoma: A viable therapeutic target? Syed DN; Aljohani A; Waseem D; Mukhtar H Semin Cancer Biol; 2018 Apr; 49():20-28. PubMed ID: 29079306 [TBL] [Abstract][Full Text] [Related]
3. RAGE Signaling in Melanoma Tumors. Olaoba OT; Kadasah S; Vetter SW; Leclerc E Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256110 [TBL] [Abstract][Full Text] [Related]
4. The HMGB1/RAGE Pro-Inflammatory Axis in the Human Placenta: Modulating Effect of Low Molecular Weight Heparin. Zenerino C; Nuzzo AM; Giuffrida D; Biolcati M; Zicari A; Todros T; Rolfo A Molecules; 2017 Nov; 22(11):. PubMed ID: 29149067 [TBL] [Abstract][Full Text] [Related]
5. Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review. Marsh AM; Nguyen AH; Parker TM; Agrawal DK Can J Physiol Pharmacol; 2017 Mar; 95(3):253-259. PubMed ID: 28092162 [TBL] [Abstract][Full Text] [Related]
6. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway. Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529 [TBL] [Abstract][Full Text] [Related]
7. Critical role of RAGE and HMGB1 in inflammatory heart disease. Bangert A; Andrassy M; Müller AM; Bockstahler M; Fischer A; Volz CH; Leib C; Göser S; Korkmaz-Icöz S; Zittrich S; Jungmann A; Lasitschka F; Pfitzer G; Müller OJ; Katus HA; Kaya Z Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E155-64. PubMed ID: 26715748 [TBL] [Abstract][Full Text] [Related]
8. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway. Ren L; Lou Y; Sun M Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479 [TBL] [Abstract][Full Text] [Related]
9. HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury. Mi L; Zhang Y; Xu Y; Zheng X; Zhang X; Wang Z; Xue M; Jin X Biomed Pharmacother; 2019 Aug; 116():109005. PubMed ID: 31136947 [TBL] [Abstract][Full Text] [Related]
10. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer. Liu-Smith F; Jia J; Zheng Y Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688 [TBL] [Abstract][Full Text] [Related]
11. Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries. Zhang BF; Song W; Wang J; Wen PF; Zhang YM J Orthop Surg Res; 2022 Jan; 17(1):20. PubMed ID: 35033142 [TBL] [Abstract][Full Text] [Related]
12. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways. Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002 [TBL] [Abstract][Full Text] [Related]
13. HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice. Tang Z; Zang N; Fu Y; Ye Z; Chen S; Mo S; Ren L; Liu E Biochem Biophys Res Commun; 2018 Jun; 501(1):1-8. PubMed ID: 29571731 [TBL] [Abstract][Full Text] [Related]
14. High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice. Ge X; Arriazu E; Magdaleno F; Antoine DJ; Dela Cruz R; Theise N; Nieto N Hepatology; 2018 Dec; 68(6):2380-2404. PubMed ID: 29774570 [TBL] [Abstract][Full Text] [Related]
15. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway. Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437 [TBL] [Abstract][Full Text] [Related]
16. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis. Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222 [TBL] [Abstract][Full Text] [Related]
17. The Immune Tolerance Role of the HMGB1-RAGE Axis. Watanabe H; Son M Cells; 2021 Mar; 10(3):. PubMed ID: 33807604 [TBL] [Abstract][Full Text] [Related]
18. HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells. Cheng M; Liu H; Zhang D; Liu Y; Wang C; Liu F; Chen J Am J Nephrol; 2015; 41(3):257-66. PubMed ID: 25924590 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases. Singh H; Agrawal DK Molecules; 2022 Oct; 27(21):. PubMed ID: 36364135 [TBL] [Abstract][Full Text] [Related]
20. Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways. Li K; Yang J; Han X Int Immunopharmacol; 2016 May; 34():114-128. PubMed ID: 26945830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]